T3D-959, an oral dual delta/gamma peroxisome proliferator-activated nuclear receptor (PPAR) agonist, has shown promise in a phase 2 randomized, placebo-controlled study of adults with mild-to-moderate ...
Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results